This so-called ‘cadherin switch’ has been documented in a variety of cancers (Tomita et al, 2000; Hardy et al, 2002), and is thought to confer on benign tumour cells the capacity to invade surrounding tissue and ultimately to metatasise to distant sites (Lee et al, 2005). Here, CDH17 is linked to neoplasm.